Tetrous

Privacy Policy

Privacy Policy for Tetrous

Last Updated: September 8, 2025

Tetrous (“we,” “us,” or “our”) is committed to protecting your privacy. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website, https://tetrous.com/ (the “Website”). Please read this policy carefully. If you do not agree with the terms of this Privacy Policy, please do not access the Website.

1. Information We Collect

We may collect information about you in the following ways:

a. Information You Provide

  • Personal Information: When you contact us, sign up for a newsletter, or engage with our services, you may provide personal information such as your name, email address, or other contact details.

  • User-Submitted Content: Information you provide through forms, comments, or other interactive features on the Website.

b. Automatically Collected Information

  • Usage Data: We collect information about your interactions with the Website, such as your IP address, browser type, device information, pages visited, and the time and date of your visit.

  • Cookies and Tracking Technologies: We use cookies, web beacons, and similar technologies to enhance your experience, analyze Website usage, and deliver personalized content. You can manage your cookie preferences through your browser settings.

c. Information from Third Parties

We may receive information about you from third-party sources, such as analytics providers or advertising partners, to improve our services and marketing efforts.

2. How We Use Your Information

We use the information we collect for the following purposes:

  • To operate and maintain the Website.

  • To respond to your inquiries, comments, or requests.

  • To send you newsletters, promotional materials, or other updates (with your consent, where required).

  • To analyze Website usage and improve our content, layout, and services.

  • To comply with legal obligations and protect our legal rights.

  • To prevent fraud and ensure the security of the Website.

3. How We Share Your Information

We do not sell, trade, or rent your personal information to third parties. We may share your information in the following circumstances:

  • Service Providers: We may share your information with third-party vendors who perform services on our behalf, such as hosting, analytics, or customer support.

  • Legal Requirements: We may disclose your information if required by law, regulation, or legal process, or to protect the rights, property, or safety of Tetrous, our users, or others.

  • Business Transfers: In the event of a merger, acquisition, or sale of assets, your information may be transferred as part of the transaction.

4. Your Choices

  • Cookies: You can set your browser to refuse cookies or alert you when cookies are being sent. Note that some parts of the Website may not function properly if cookies are disabled.

  • Opt-Out: If you receive marketing communications from us, you can opt out by following the unsubscribe instructions in the email or by contacting us directly.

  • Access and Correction: Depending on your jurisdiction, you may have the right to access, correct, or delete your personal information. Please contact us to exercise these rights.

5. Data Security

We implement reasonable technical and organizational measures to protect your information from unauthorized access, loss, or misuse. However, no method of transmission over the internet or electronic storage is 100% secure, and we cannot guarantee absolute security.

6. Third-Party Links

The Website may contain links to third-party websites or services. We are not responsible for the privacy practices or content of these third parties. We encourage you to review the privacy policies of any third-party sites you visit.

7. Children’s Privacy

The Website is not intended for individuals under the age of 13. We do not knowingly collect personal information from children under 13. If you believe we have collected such information, please contact us to request its deletion.

8. International Users

If you access the Website from outside the United States, your information may be transferred to, stored, and processed in the United States or other jurisdictions where our servers or service providers are located. By using the Website, you consent to this transfer.

9. Changes to This Privacy Policy

We may update this Privacy Policy from time to time. Any changes will be posted on this page with an updated “Last Updated” date. Your continued use of the Website after such changes constitutes your acceptance of the updated policy.

10. Contact Us

If you have any questions or concerns about this Privacy Policy or our data practices, please contact us at:

Tetrous
Email: info@tetrous.com

Bradley E. Patt, PhD

Dr. Patt is cofounder chairman of Tetrous.

Brad has over 40 years experience as an entrepreneur and executive manager. He has led several enterprises from start-up phase through rapid growth and merger and acquisitions.

Brad founded several high tech ventures since 1997. He is currently co-founder chairman and CEO of TheraCell and DermOQ. Previously he was co-founder, CEO and Chairman of Gamma Medica, Inc. Brad built Gamma to market leadership position in pre­clinical CT, PET, SPECT imaging and is inventor and developer of Molecular Breast Imaging for detecting otherwise occult breast cancer in dense­breasted women.

Brad is currently co­founder and Chairman of DermOQ, Inc., an oxygen skin care company; EVO Worldwide, Inc. and spin off Smart Breast Corp., medical diagnostic imaging systems companies; and Hyvida Brands, a functional beverage startup. He is a director of High Beauty a cannabis cosmetic company. Brad also founded and is a Director of Thrive Outside the Box, a nonprofit organization that identifies and develops areas of talent in individuals on the autistic spectrum.

Brad is an internationally recognized authority in the field of medical imaging with over one hundred scientific papers and presentations, several book chapters, and over 20 patents. He has been an invited speaker at several international conferences. He has held elected positions on the IEEE Nuclear Medicine Instrumentation Steering Committee (NMISC) and the IEEE Radiation Instrumentation Steering Committee (RISC), and was appointed to the Program Committee of the SPIE Medical applications of Penetrating Radiation, acting as Chairman of the Penetrating Radiation Work Group for 2003 and 2004. Dr. Patt is a consultant to the National Institutes of Health and the recipient of over $15 million dollars of grant awards as Principal Investigator from the National Institutes of Health, The United States Department of Energy and NASA.

Bradley E. Patt, PhD

Dr. Patt is cofounder chairman of Tetrous. Brad has over 40 years experience as an entrepreneur and executive manager. He has led several enterprises from start-up phase through rapid growth and merger and acquisitions. Brad founded several high tech ventures since 1997. He is currently co-founder chairman and CEO of TheraCell and DermOQ. Previously he was co-founder, CEO and Chairman of Gamma Medica, Inc. Brad built Gamma to market leadership position in pre­clinical CT, PET, SPECT imaging and is inventor and developer of Molecular Breast Imaging for detecting otherwise occult breast cancer in dense­breasted women. Brad is currently co­founder and Chairman of DermOQ, Inc., an oxygen skin care company; EVO Worldwide, Inc. and spin off Smart Breast Corp., medical diagnostic imaging systems companies; and Hyvida Brands, a functional beverage startup. He is a director of High Beauty a cannabis cosmetic company. Brad also founded and is a Director of Thrive Outside the Box, a nonprofit organization that identifies and develops areas of talent in individuals on the autistic spectrum. Brad is an internationally recognized authority in the field of medical imaging with over one hundred scientific papers and presentations, several book chapters, and over 20 patents. He has been an invited speaker at several international conferences. He has held elected positions on the IEEE Nuclear Medicine Instrumentation Steering Committee (NMISC) and the IEEE Radiation Instrumentation Steering Committee (RISC), and was appointed to the Program Committee of the SPIE Medical applications of Penetrating Radiation, acting as Chairman of the Penetrating Radiation Work Group for 2003 and 2004. Dr. Patt is a consultant to the National Institutes of Health and the recipient of over $15 million dollars of grant awards as Principal Investigator from the National Institutes of Health, The United States Department of Energy and NASA.